These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24972790)

  • 1. Cryoprecipitate therapy.
    Nascimento B; Goodnough LT; Levy JH
    Br J Anaesth; 2014 Dec; 113(6):922-34. PubMed ID: 24972790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial.
    Karkouti K; Callum J; Rao V; Heddle N; Farkouh ME; Crowther MA; Scales DC
    BMJ Open; 2018 Apr; 8(4):e020741. PubMed ID: 29678987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cryoprecipitate: that old unknown.
    Blasi A; Beltran J; Pereira A; Puig L
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):204-12. PubMed ID: 25561426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen Replacement Therapy for Traumatic Coagulopathy: Does the Fibrinogen Source Matter?
    Morrow GB; Carlier MSA; Dasgupta S; Craigen FB; Mutch NJ; Curry N
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review.
    Jensen NH; Stensballe J; Afshari A
    Acta Anaesthesiol Scand; 2016 Sep; 60(8):1033-42. PubMed ID: 27109179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cryoprecipitate in human and canine transfusion medicine.
    Prittie J
    J Vet Emerg Crit Care (San Antonio); 2021 Mar; 31(2):204-214. PubMed ID: 33751762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial.
    Downey LA; Andrews J; Hedlin H; Kamra K; McKenzie ED; Hanley FL; Williams GD; Guzzetta NA
    Anesth Analg; 2020 Mar; 130(3):740-751. PubMed ID: 31490252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoprecipitate for the correction of coagulopathy associated with liver disease.
    French CJ; Bellomo R; Angus P
    Anaesth Intensive Care; 2003 Aug; 31(4):357-61. PubMed ID: 12973957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.
    Idris SF; Hadjinicolaou AV; Sweeney M; Winthrop C; Balendran G; Besser M
    Br J Haematol; 2014 Aug; 166(3):458-61. PubMed ID: 24725203
    [No Abstract]   [Full Text] [Related]  

  • 10. Cryoprecipitate transfusion in bleeding patients.
    Nascimento B; Levy JH; Tien H; Da Luz LT
    CJEM; 2020 Sep; 22(S2):S4-S11. PubMed ID: 33084562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted cryoprecipitate transfusion in severe traumatic haemorrhage.
    Ho D; Chan E; Campbell D; Wake E; Walters K; Bulmer AC; McCullough J; Wullschleger M; Winearls J
    Injury; 2020 Sep; 51(9):1949-1955. PubMed ID: 32553426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M; Del Vecchio A; Radicioni M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma.
    Nascimento B; Rizoli S; Rubenfeld G; Fukushima R; Ahmed N; Nathens A; Lin Y; Callum J
    Transfus Med; 2011 Dec; 21(6):394-401. PubMed ID: 21851429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate.
    Shibahashi K; Nishimura S; Sugiyama K; Hoda H; Hamabe Y; Fujita H
    Neurol Med Chir (Tokyo); 2019 Oct; 59(10):371-378. PubMed ID: 31281170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective prophylactic solvent-detergent plasma and cryoprecipitate transfusion to prevent intraventricular hemorrhage in extreme preterm infants: A case-historical control.
    Al-Abdi S; Dabelah K; Mousa T; Ul-Rahman N; Matar K; Sheta A; Algirim H
    J Neonatal Perinatal Med; 2018; 11(3):241-248. PubMed ID: 30282376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoprecipitate: an outmoded treatment?
    Yang L; Stanworth S; Baglin T
    Transfus Med; 2012 Oct; 22(5):315-20. PubMed ID: 22994448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.
    Galas FR; de Almeida JP; Fukushima JT; Vincent JL; Osawa EA; Zeferino S; Câmara L; Guimarães VA; Jatene MB; Hajjar LA
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1647-55. PubMed ID: 24951020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoprecipitate administration after trauma.
    Olaussen A; Fitzgerald MC; Tan GA; Mitra B
    Eur J Emerg Med; 2016 Aug; 23(4):269-273. PubMed ID: 25734480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When do we transfuse cryoprecipitate?
    Anderson MA; Glazebrook B; Cutts B; Stevenson L; Bielby L; Borosak M
    Intern Med J; 2013 Aug; 43(8):896-902. PubMed ID: 23425520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation.
    Okerberg CK; Williams LA; Kilgore ML; Kim CH; Marques MB; Schwartz J; Pham HP
    Vox Sang; 2016 Oct; 111(3):292-298. PubMed ID: 27248502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.